Vivek’s company invested $116 million in nanoparticle delivery systems in 2017. Also, according to @DrDMartinWorld, “he (Vivek) has a not-so-publicly-disclosed interest in every shot that was delivered.”
(How many of us have a portion of our retirement funds invested in such companies via mutual funds?)
Published by markskidmore
Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.
View more posts